{
}
AstraZeneca and Daiichi Sankyo announced new study results for their cancer drug datopotamab deruxtecan, showing a median survival of 15.6 months in patients with EGFR-mutated non-small cell lung cancer. Agenus plans to cut annual spending by 60% to focus on a late-stage cancer immunotherapy, while Amgen is investing $1 billion to expand its manufacturing in North Carolina. The U.S. Patent and Trademark Office has withdrawn a proposed rule aimed at reducing patent thickets, and Bluebird bio is executing a reverse stock split to comply with Nasdaq rules. Merus received FDA accelerated approval for zenocutuzumab, its first approved product.
Merck & Co. has acquired Modifi Biosciences for $30 million, with potential additional payments of up to $1.3 billion based on milestones. Meanwhile, Roche reported that sales of Sarepta's gene therapy Elevidys reached approximately $156 million outside the U.S. in the first nine months of the year. Sangamo Therapeutics is on track to file for accelerated approval of its Fabry disease treatment, while MacroGenics sold rights to its breast cancer drug Margenza for $40 million, with additional milestone payments possible.
Delilah Alvarado
People
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
AstraZeneca and Daiichi Sankyo Advance Cancer Drug Amid Industry Developments
bluebird bio, Inc.
AstraZeneca PLC
Daiichi Sankyo Co Ltd
Amgen Inc.
Merus N.V.
Delilah Alvarado
Ned Pagliarulo
Jonathan Gardner
Ben Fidler
Show more
01:00 06.12.2024
merck acquires cancer startup elevidys sales rise and other industry updates
United States Dollar
Swiss Franc
Hoffmann-La Roche AG
Merck & Co., Inc.
UCB SA
Sarepta Therapeutics, Inc.
Sangamo Therapeutics, Inc.
Ned Pagliarulo
Delilah Alvarado
Jonathan Gardner
Alessandro Maselli
Show more
17:45 23.10.2024
Trending
Subcategory
Corporate News
Industry Trends
Startups & Entrepreneurship
Global Trade Developments
Retail and Consumer Goods
Supply Chain Management
Stock Market Updates
Government Economic Policies
Private Equity Deals
Industry Mergers & Acquisitions
Venture Capital Investments
Fintech Startups
Funding Rounds & Investments
Energy Sector Developments
IPOs & SPACs
AI Innovations
Emerging Startups
Decentralized Finance (DeFi) Innovations
Inflation and Monetary Impact
Economic Indicators
Countries:
Companies:
Apple Inc.
NVIDIA Corp
Mastercard Inc
Tesmec S.p.A.
Ripple USD USD
The Goldman Sachs Group, Inc.
Visa Inc.
Micron Technology, Inc.
SWIGGY LIMITED
SAP SE
Ather Energy Ltd.
GLOE Inc.
Microsoft Corporation
J.P. Morgan Fixed Income Opps A EUR Inc
S&P 500
J&T EXPRESS-W
NAURA Technology Group Co., Ltd.
Bajaj Auto Limited
OLA ELECTRIC MOBILITY LTD
Teradyne, Inc.
Currencies:
United States Dollar
Indian Rupee
Chinese Yuan
Euro
Japanese Yen
Saudi Riyal
United Arab Emirates Dirham
Canadian Dollar
Indonesian Rupiah
South Korean Won
Malaysian Ringgit
Brazilian Real
Swiss Franc
New Zealand Dollar
British Pound Sterling
Qatari Riyal
Bangladeshi Taka
Kuwaiti Dinar
People: